Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kokkinos, J.
Right arrow Articles by Levine, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kokkinos, J.
Right arrow Articles by Levine, S. R.

Stroke, Vol 24, 310-313, Copyright © 1993 by American Heart Association


ARTICLES

Possible association of ischemic stroke with phentermine

J Kokkinos and SR Levine
Department of Neurology, Henry Ford Hospital and Health Sciences Center, Detroit, MI 48202-2689.

BACKGROUND AND PURPOSE: Some commonly used anorexiants, including methamphetamine and phenylpropanolamine, have been associated with stroke. Because phentermine is an anorexiant with a chemical structure similar to that of amphetamines, similar side effects might be expected. CASE DESCRIPTIONS: Two patients using phentermine (one was also using phendimetrazine) developed ischemic cerebrovascular disease. One suffered a cerebral infarct with angiographic evidence of vasculopathy involving multiple vascular beds. The other patient developed headache and a hemisensory disturbance of 7 days' duration. CONCLUSIONS: Phentermine, and possibly phendimetrazine, should be considered an anorexiant and sympathomimetic drug that can be associated with ischemic cerebrovascular disease.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
Z. Li, M. Maglione, W. Tu, W. Mojica, D. Arterburn, L. R. Shugarman, L. Hilton, M. Suttorp, V. Solomon, P. G. Shekelle, et al.
Meta-Analysis: Pharmacologic Treatment of Obesity
Ann Intern Med, April 5, 2005; 142(7): 532 - 546.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Cantu, A. Arauz, L. M. Murillo-Bonilla, M. Lopez, and F. Barinagarrementeria
Stroke Associated With Sympathomimetics Contained in Over-the-Counter Cough and Cold Drugs
Stroke, July 1, 2003; 34(7): 1667 - 1672.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Caccitolo, H. M. Connolly, D. S. Rubenson, T. A. Orszulak, and H. V. Schaff
Operation for anorexigen-associated valvular heart disease
J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 656 - 664.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Sobieraj, D. B. Schembre, K. K. Boynton, A. P. Fishman, R. M. Hoffman, D. Upson, N. V. Dhurandhar, R. L. Atkinson, D. F. Williamson, L. Abenhaim, et al.
Appetite-Suppressant Drugs and Primary Pulmonary Hypertension
N. Engl. J. Med., February 13, 1997; 336(7): 510 - 513.
[Full Text]